Gallop Oncology, a company founded by PureTech Health (NASDAQ: PRTC, LSE: PRTC), announced initial results from its Phase 1b clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE